Sarah Cannon Research Institute is partnering with pharmaceutical giant Pfizer Inc. to accelerate oncology drug development. 

The Nashville-based oncology research organization announced the partnership Wednesday, stating the collaboration will advance the development of Pfizer’s oncology portfolio and bring therapies to patients faster than otherwise.